Complementing CD20 antibodies' effector functions

Jeanette H.W. Leusen

doi:10.1182/blood.2024027767

2025-03-20

PRE

Jeanette H.W. Leusen

Thomas Valerius

DOI：10.1182/blood.2024027767

原文链接

原文求助

摘要

En 中文

在本期《Blood》杂志中，Baskar等人描述了一种创新方法，通过利用其补体激活能力沉积C3d作为新抗原，以增强CD20抗体的疗效，该方法在异种移植小鼠模型中得到验证。1

期刊

Blood

IF:

23.1

论文数:

5.6K

被引数:

16.6W

机构

Christian Albrechts Univ Kiel

学者数:

237

论文数: 120

被引数: 42

Univ Med Ctr Utrecht

学者数:

818

论文数: 455

被引数: 144

引用论文

Next generation antibody drugs: pursuit of the 'high-hanging fruit'

NATURE REVIEWS DRUG DISCOVERY

IF101.8

2017-12-01

609

PREAI

Carter, Paul J.; Lazar, Greg A.

Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab

Science

IF0

2020-03-13

OAAI

Lionel Rougé; Nancy Chiang; Micah Steffek; Christine Kugel; Tristan I. Croll; Christine Tam; Alberto Estevez; Christopher P. Arthur; Christopher M. Koth; Claudio Ciferri; Edward Kraft; Jian Payandeh; Gerald Nakamura; James T. Koerber; Alexis Rohou

Unlocking the Power of Complement-Dependent Cytotoxicity: Engineering Strategies for the Development of Potent Therapeutic Antibodies for Cancer Treatments

BIODRUGS

IF6.9

2023-07-24

PREAI

Lee, Wonju; Lee, Sang Min; Jung, Sang Taek

Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study 达拉妥单抗在儿科复发/难治性急性淋巴细胞白血病或淋巴母细胞淋巴瘤中的应用：DELPHINUS研究

Blood

IF0

2024-11-21

OAAI

Teena Bhatla; Laura E. Hogan; David T. Teachey; Francisco Bautista; John Moppett; Pablo Velasco Puyó; Concetta Micalizzi; Claudia Rossig; Neerav Shukla; Gil Gilad; Franco Locatelli; André Baruchel; C. Michel Zwaan; Natalie S. Bezler; Alba Rubio-San-Simón; David C. Taussig; Elizabeth A. Raetz; Zhengwei J. Mao; Brent L. Wood; Diana Alvarez Arias; Maria Krevvata; Ivo Nnane; Nibedita Bandyopadhyay; Lorena Lopez Solano; Robyn M. Dennis; Robin Carson; Ajay Vora

A guide to complement biology, pathology and therapeutic opportunity

NATURE REVIEWS IMMUNOLOGY

IF60.9

2023-09-05

PREAI

Mastellos, Dimitrios C.; Hajishengallis, George; Lambris, John D.

An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab

Blood

IF0

2003-02-01

OAAI

Adam D. Kennedy; Michael D. Solga; Theodore A. Schuman; Amos W. Chi; Margaret A. Lindorfer; William M. Sutherland; Patricia L. Foley; Ronald P. Taylor

Complement‐targeted therapeutics: Are we there yet, or just getting started?互补靶向疗法: 我们还在那里，还是刚刚开始？

European Journal of Immunology

IF0

2024-09-12

OAAI

Daniel Ricklin

Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-08-31

OAAI

Gehlert, Carina Lynn; Rahmati, Pegah; Boje, Ammelie Svea; Winterberg, Dorothee; Krohn, Steffen; Theocharis, Thomas; Cappuzzello, Elisa; Lux, Anja; Nimmerjahn, Falk; Ludwig, Ralf J.; Lustig, Marta; Roesner, Thies; Valerius, Thomas; Schewe, Denis Martin; Kellner, Christian; Klausz, Katja; Peipp, Matthias

Complement Is Activated by IgG Hexamers Assembled at the Cell Surface

Science

IF0

2014-03-14

OAAI

Christoph A. Diebolder; Frank J. Beurskens; Rob N. de Jong; Roman I. Koning; Kristin Strumane; Margaret A. Lindorfer; Marleen Voorhorst; Deniz Ugurlar; Sara Rosati; Albert J. R. Heck; Jan G. J. van de Winkel; Ian A. Wilson; Abraham J. Koster; Ronald P. Taylor; Erica Ollmann Saphire; Dennis R. Burton; Janine Schuurman; Piet Gros; Paul W. H. I. Parren

没有更多内容